Investing.com -- Raymond James downgraded Danaher Corporation (NYSE:DHR) to "Market Perform" from "Outperform," citing concerns over the company's growth trajectory following its fourth-quarter results and guidance that lagged peers.
The brokerage noted that Danaher's high-value portfolio, previously expected to generate leading growth, now appears less compelling as its organic growth forecast of about 3% offers limited upside compared to rivals. Analysts also flagged a lack of confidence in the company's long-term earnings growth outlook, calling management’s tone on key metrics "unsettling."
Raymond (NSE:RYMD) James said it expects the stock’s valuation premium over competitors like Thermo Fisher (NYSE:TMO) to compress, as Danaher is "not poised for major outperformance" and may struggle to justify its historical premium.
Meanwhile, the brokerage reiterated an "Outperform" rating on Thermo Fisher, highlighting its clearer growth outlook and relative valuation discount.
Related Articles
Raymond James downgrades Danaher on murky growth outlook
Canada Goose stock falls on new US tariffs
Factbox-From Johnnie Walker to Corona beer, major alcohol firms could see tariff hit
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。